Samuel E Vaughn
5PUBLICATIONS
13CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Mar 18, 2026
Impact of CYP2D6 Genotype and Inhibitor Use on Risperidone Metabolism in Children: Functional Insights Into the *17 and *29 Alleles.Matthew H Bennett, Ethan A Poweleit, Samuel E Vaughn
|Jul 24, 2025
Cytochrome P450 2D6 *17 and *29 Allele Activity for Risperidone Metabolism: Advancing Precision Medicine Health Equity.Oyinlade Kehinde, Samuel E Vaughn, Ogochukwu Amaeze
|Jul 26, 2024
Catatonia responsive to corticosteroids in a patient with an SCN2A variant.Kimberly Senko, Kelsey L Saddoris, Ella Baus
|Feb 20, 2024
Influence of CYP2D6 Metabolizer Status on Risperidone and Paliperidone Tolerability in Children and Adolescents.Amarachi A Kanu, Michelle M Johnston, Ethan A Poweleit
|Feb 01, 2024
Machine Learning-Based Prediction of Escitalopram and Sertraline Side Effects With Pharmacokinetic Data in Children and Adolescents.Ethan A Poweleit, Samuel E Vaughn, Zeruesenay Desta
Pageof 1
Frequent Collaborators
4 joint publications
Laura B Ramsey
3 joint publications
Jeffrey R Strawn
2 joint publications
Ethan A Poweleit
2 joint publications
Brandon Retke
1 joint publications
Zeruesenay Desta
1 joint publications
Judith W Dexheimer
1 joint publications
Kimberly Senko
1 joint publications
Kelsey L Saddoris
1 joint publications
Katherine Soe
1 joint publications
Oyinlade Kehinde
